Psyence Biomedical Ltd. (PBM)
4.20
-0.13
(-3.00%)
USD |
NASDAQ |
Aug 24, 16:00
4.20
0.00 (0.00%)
After-Hours: 20:00
Psyence Biomedical Total Liabilities (Quarterly) : 0.9431M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 0.9431M |
| September 30, 2024 | 3.509M |
| December 31, 2023 | |
| September 30, 2023 | 16.18M |
| June 30, 2023 | 15.26M |
| March 31, 2023 | 14.88M |
| December 31, 2022 | 14.27M |
| Date | Value |
|---|---|
| September 30, 2022 | 14.07M |
| June 30, 2022 | 14.23M |
| March 31, 2022 | 16.38M |
| December 31, 2021 | 19.58M |
| September 30, 2021 | 0.2725M |
| June 30, 2021 | 0.1937M |
| March 31, 2021 | 0.0782M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 53.38M |
| Aurinia Pharmaceuticals, Inc. | 177.40M |
| enGene Therapeutics, Inc. | 52.36M |
| Medicus Pharma Ltd. | 20.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.81M |
| Shareholders Equity (Quarterly) | 11.87M |